No. 945New York · London · SingaporeUpdated July 23, 2026

Financial News
& Market Press Releases

SERSER: Serina Therapeutics locks in $500,000 CEO salary with 1.5x change-in-control severanceJul 23HBANHBAN holds common dividend at $0.155 as Huntington board sets seven preferred payouts through NovemberJul 23CFFIC&F Financial files Q2 2026 investor presentation, outlining auto finance risks and strategic frameworkJul 23MARKETSHedge funds circle UK stocks as Prime Minister Andy Burnham pledges 'new economic model'Jul 23MARKETS10-year Treasury yield clears 4.7%, highest print since January 2025Jul 23MARKETS10-year Treasury yield hits January 2025 high as oil surge fans inflation fearsJul 23MARKETSPace of withdrawals slowing at Blackstone's flagship private credit fund, BX in focusJul 23MARKETSRivian (RIVN) slides 18% in extended hours after 75-million-share offeringJul 23MARKETSSamsung-backed Rebellions targets KOSPI for South Korea IPO, CEO tells CNBCJul 23MARKETSLuxshare falls more than 5% in Hong Kong debut after HK$24.27 billion offeringJul 23SERSER: Serina Therapeutics locks in $500,000 CEO salary with 1.5x change-in-control severanceJul 23HBANHBAN holds common dividend at $0.155 as Huntington board sets seven preferred payouts through NovemberJul 23CFFIC&F Financial files Q2 2026 investor presentation, outlining auto finance risks and strategic frameworkJul 23MARKETSHedge funds circle UK stocks as Prime Minister Andy Burnham pledges 'new economic model'Jul 23MARKETS10-year Treasury yield clears 4.7%, highest print since January 2025Jul 23MARKETS10-year Treasury yield hits January 2025 high as oil surge fans inflation fearsJul 23MARKETSPace of withdrawals slowing at Blackstone's flagship private credit fund, BX in focusJul 23MARKETSRivian (RIVN) slides 18% in extended hours after 75-million-share offeringJul 23MARKETSSamsung-backed Rebellions targets KOSPI for South Korea IPO, CEO tells CNBCJul 23MARKETSLuxshare falls more than 5% in Hong Kong debut after HK$24.27 billion offeringJul 23

NewsMacro · CFFI

C&F Financial files Q2 2026 investor presentation, outlining auto finance risks and strategic framework

A Regulation FD 8-K from C&F Financial Corporation (NASDAQ: CFFI) put a Second Quarter 2026 investor presentation into the public record, sketching the company's strategic framework and the non-GAAP measures management tracks alongside reported results. The filing carries no new earnings figures. Actual Q2 2026 numbers, against which the presentation's performance framework can be compared, will arrive with the Corporation's next periodic SEC filing.

By Marcus ColeMacro DeskJuly 23, 20262 min readCFFI

C&F Financial Corporation (NASDAQ: CFFI) filed a Regulation FD 8-K placing its Second Quarter 2026 investor presentation into the public record, but the filing contains no new earnings figures.
The investor presentation is anchored by seven strategic pillars: Performance & Growth, Our People, Marketing & Brand Recognition, Community Engagement, Cross Company Collaboration, Efficiency and Technology, and Risk Management.
The presentation names used automobile pricing and inventory as a distinct risk factor, citing repossessed vehicle sales prices, auto finance installment contract delinquencies, and the Corporation's ability to recover collateral.
Rate sensitivity risks listed include Federal Reserve policy moves, short-term interest rate volatility, Treasury yield swings, and mortgage rate fluctuations, while tariffs, trade policy, and geopolitical tensions fall under general market conditions.
Actual Q2 2026 results will arrive with the Corporation's next periodic SEC filing, which is the next confirmable data point.

The strategic frame

Seven pillars anchor the investor presentation: Performance & Growth, Our People, Marketing & Brand Recognition, Community Engagement, Cross Company Collaboration, Efficiency and Technology, and Risk Management. Management positions the company as having unique competitive advantages and as prepared to deliver substantial value creation through what it describes as a clear long-term strategy.

The presentation lists several non-GAAP measures in active use: adjusted net income, adjusted earnings per share, adjusted return on average equity, adjusted return on average assets, return on average tangible common equity (ROATCE), adjusted ROATCE, tangible common equity to tangible assets, and tangible book value per share. Reconciliations to the nearest GAAP equivalents are included in an appendix. For the full risk picture, the Corporation points to its Annual Report on Form 10-K for the year ended December 31, 2025.

Where the physical exposure sits

The forward-looking statement section names used automobile pricing and inventory as a distinct risk factor, flagging fluctuations in the sales prices of repossessed vehicles, delinquency levels on auto finance installment contracts, and the Corporation's ability to recover collateral. Taken together, those items put the used car market squarely inside the Corporation's risk profile, running from loan origination through the back end of the collateral recovery cycle.

Rate sensitivity receives parallel treatment. The document lists Federal Reserve policy moves, short-term interest rate volatility, Treasury yield swings, and mortgage rate fluctuations as factors that could materially affect results. Tariffs and trade policy appear alongside geopolitical tensions in the general market conditions category.

What to watch

No new transaction or material event is signaled in this filing. The presentation is available through the Corporation's website at cffc.com. The next confirmable data point is the periodic filing that carries Q2 2026 actuals.

More from the Newsroom

All stories →

01Macro · SER

SER: Serina Therapeutics locks in $500,000 CEO salary with 1.5x change-in-control severance

A new employment contract for Serina Therapeutics Chief Executive Officer Steve Ledger, executed July 19, 2026 and disclosed via SEC Form 8-K, sets a $500,000 annual base salary and a 50% target annual bonus, lifting the total target cash figure to $750,000 annually. The Amended

Grace Osei2 min read

02Macro · HBAN

HBAN holds common dividend at $0.155 as Huntington board sets seven preferred payouts through November

In focus for HBAN: a board-declared quarterly cash dividend of $0.155 per common share, matching the prior quarter's print exactly. The next confirmable date is September 17, 2026, the record date for a payment Huntington Bancshares Incorporated has scheduled for October 1.

Nadia Petrova2 min read

03Macro

Hedge funds circle UK stocks as Prime Minister Andy Burnham pledges 'new economic model'

U.K. equities are in focus as hedge funds begin circling the market around Prime Minister Andy Burnham's commitment to deliver a "new economic model" for Britain. Burnham's overhaul of domestic policy could fuel [a range of trading opportunities across U.K. stocks](/news/bae-syst

Ines Ferreira2 min read

Frequently asked

Does the filing include new earnings numbers?

No, the Regulation FD 8-K and investor presentation carry no new earnings figures; actual Q2 2026 numbers will come with the Corporation's next periodic SEC filing.

What non-GAAP measures does management track?

The presentation lists adjusted net income, adjusted earnings per share, adjusted return on average equity, adjusted return on average assets, ROATCE, adjusted ROATCE, tangible common equity to tangible assets, and tangible book value per share, with GAAP reconciliations in an appendix.

Why is the used car market relevant to C&F Financial's risk profile?

The forward-looking statements flag used automobile pricing and inventory as a risk factor, covering repossessed vehicle sales prices, auto finance installment contract delinquencies, and collateral recovery from loan origination through the collateral recovery cycle.

Where can the investor presentation be accessed?

The presentation is available through the Corporation's website at cffc.com.

Where does the Corporation direct readers for the full risk picture?

The Corporation points to its Annual Report on Form 10-K for the year ended December 31, 2025, for the full risk picture.